Datasheet

Conforms to Regulation (EC) No. 1907/2006 (REACH), Annex II, as amended by Commission Regulation (EU)
2015/830
Chemask® Lead-Free
SECTION 11: Toxicological information
Potential chronic health effects
Potential acute health effects
Inhalation
:
Toxic if inhaled.
Toxic if swallowed.
:
Ingestion
Skin contact
:
Toxic in contact with skin.
May cause eye irritation.
:
Eye contact
No known significant effects or critical hazards.
General
:
Not available.
Conclusion/Summary
:
Not available.
Symptoms related to the physical, chemical and toxicological characteristics
Skin contact
Ingestion
Inhalation
Adverse symptoms may include the following:
drowsiness/fatigue
headache
respiratory tract irritation
Adverse symptoms may include the following:
Irritating to mouth, throat and stomach.
Ingestion Seek medical attention.
Adverse symptoms may include the following:
irritation
redness
dryness
sensitiser May cause allergic reactions in certain individuals.
:
:
:
Eye contact
:
Adverse symptoms may include the following:
pain or irritation
redness
watering
Not available.
Specific target organ toxicity (repeated exposure)
Product/ingredient name
Category
Aspiration hazard
Route of
exposure
Target organs
Information on likely routes
of exposure
:
Delayed and immediate effects as well as chronic effects from short and long-term exposure
Short term exposure
Long term exposure
Potential immediate
effects
Potential delayed effects
:
:
Potential immediate
effects
Potential delayed effects
:
:
Not available.
Not available.
Not available.
Not available.
Not available.
methanol
Category 1
Not determined
Not determined
zinc bis(dibutyldithiocarbamate)
Category 3
Not applicable.
Respiratory tract
irritation
ammonia
Category 3
Not applicable.
Respiratory tract
irritation
Not available.
Date of issue/Date of revision
:
5/15/2017
Date of previous issue
:
No previous validation
Version
:
1
10/15